BJCM
GMED icon

Blue Jay Capital Management’s Globus Medical GMED Stock Holding History

Blue Jay Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-400,000
Closed -$11.8M – 23
2017
Q1 		$11.8M Buy
+400,000
New +$10.9M 5.82% 3
2015
Q1 		– Sell
-275,000
Closed -$6.54M – 23
2014
Q4 		$6.54M Buy
+275,000
New +$6.09M 2.91% 23

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Blue Jay Capital Management's GMED Position: Q2 2017 in Review

Blue Jay Capital Management sold out of Globus Medical (GMED) in Q2 2017, closing a stake of 400,000 shares — an estimated $11.8M sold.

Blue Jay Capital Management first reported a position in GMED in Q4 2014 and held it in 2 quarters. The position peaked at $11.8M in Q1 2017. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

  • Blue Jay Capital Management reported no remaining Globus Medical position as of Q2 2017 after selling out during the quarter.
  • Blue Jay Capital Management sold 400,000 Globus Medical shares in Q2 2017, an estimated $11.8M.
  • Blue Jay Capital Management first reported a position in Globus Medical in Q4 2014 and held it in 2 quarters.
  • Blue Jay Capital Management's Globus Medical position peaked at $11.8M in Q1 2017.
  • 244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.